HK1207570A1 - 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n- ethyl-hept-4-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof ii 7-[35--2-(3--5---1-)-]-n-- -5-() - Google Patents
7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n- ethyl-hept-4-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof ii 7-[35--2-(3--5---1-)-]-n-- -5-()Info
- Publication number
- HK1207570A1 HK1207570A1 HK15108218.2A HK15108218A HK1207570A1 HK 1207570 A1 HK1207570 A1 HK 1207570A1 HK 15108218 A HK15108218 A HK 15108218A HK 1207570 A1 HK1207570 A1 HK 1207570A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- bimatoprost
- enamide
- pent
- hept
- Prior art date
Links
- LIMAHHNLNFGHIW-UHFFFAOYSA-N 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpent-1-enyl)cyclopentyl]-N-ethylhept-4-enamide Chemical compound OC1C(C(C(C1)O)CCC=CCCC(=O)NCC)C=CC(CCC1=CC=CC=C1)O LIMAHHNLNFGHIW-UHFFFAOYSA-N 0.000 title 1
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 title 1
- 229960002470 bimatoprost Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/39—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26347109P | 2009-11-23 | 2009-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1207570A1 true HK1207570A1 (en) | 2016-02-05 |
Family
ID=43639099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15108218.2A HK1207570A1 (en) | 2009-11-23 | 2015-08-25 | 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n- ethyl-hept-4-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof ii 7-[35--2-(3--5---1-)-]-n-- -5-() |
Country Status (19)
Country | Link |
---|---|
US (2) | US8629185B2 (xx) |
EP (1) | EP2504313A1 (xx) |
JP (2) | JP5921439B2 (xx) |
KR (1) | KR20120085330A (xx) |
CN (2) | CN104367580A (xx) |
AU (1) | AU2010321831B2 (xx) |
BR (1) | BR112012012387A2 (xx) |
CA (1) | CA2781698A1 (xx) |
CL (1) | CL2012001339A1 (xx) |
CO (1) | CO6551754A2 (xx) |
HK (1) | HK1207570A1 (xx) |
IL (2) | IL219959A (xx) |
IN (1) | IN2012DN05209A (xx) |
MX (1) | MX2012005968A (xx) |
NZ (1) | NZ600263A (xx) |
RU (1) | RU2577546C2 (xx) |
UA (1) | UA110696C2 (xx) |
WO (1) | WO2011063276A1 (xx) |
ZA (1) | ZA201203883B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367580A (zh) * | 2009-11-23 | 2015-02-25 | 阿勒根公司 | 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法 |
CA2837261C (en) | 2011-06-02 | 2020-12-15 | CHINOIN Zrt. | Novel processes for the preparation of prostaglandin amides |
PT2911623T (pt) | 2012-10-26 | 2019-11-21 | Forsight Vision5 Inc | Sistema oftálmico para libertação prolongada de fármaco no olho |
DK2934510T3 (da) * | 2012-12-19 | 2021-01-25 | Novartis Ag | Lfa-1-inhibitorformuleringer |
US9447014B2 (en) | 2012-12-28 | 2016-09-20 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof |
US9120738B2 (en) | 2012-12-28 | 2015-09-01 | Allergan, Inc. | Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof |
US10273206B2 (en) | 2014-06-27 | 2019-04-30 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereof |
EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
CN115677549A (zh) * | 2022-10-27 | 2023-02-03 | 神隆医药(常熟)有限公司 | 一种贝美前列素手性异构体的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU403156A3 (xx) * | 1968-07-29 | 1973-10-19 | ||
IL143477A (en) * | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
JP2004518612A (ja) * | 2000-07-28 | 2004-06-24 | インスパイアー ファーマシューティカルズ,インコーポレイティド | インドール誘導体を用いて眼圧を下降させる方法 |
DE602004016563D1 (de) * | 2003-12-30 | 2008-10-23 | Metabolix Inc | Nukleierungsmittel |
IL177762A0 (en) * | 2006-08-29 | 2006-12-31 | Arieh Gutman | Bimatoprost crystalline form i |
CN104367580A (zh) * | 2009-11-23 | 2015-02-25 | 阿勒根公司 | 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法 |
-
2010
- 2010-11-19 CN CN201410542159.6A patent/CN104367580A/zh active Pending
- 2010-11-19 AU AU2010321831A patent/AU2010321831B2/en active Active
- 2010-11-19 CN CN201080062129.5A patent/CN102712584B/zh active Active
- 2010-11-19 RU RU2012125185/04A patent/RU2577546C2/ru active
- 2010-11-19 IN IN5209DEN2012 patent/IN2012DN05209A/en unknown
- 2010-11-19 JP JP2012541130A patent/JP5921439B2/ja active Active
- 2010-11-19 MX MX2012005968A patent/MX2012005968A/es not_active Application Discontinuation
- 2010-11-19 BR BR112012012387A patent/BR112012012387A2/pt not_active IP Right Cessation
- 2010-11-19 EP EP10785274A patent/EP2504313A1/en not_active Ceased
- 2010-11-19 CA CA2781698A patent/CA2781698A1/en not_active Abandoned
- 2010-11-19 NZ NZ600263A patent/NZ600263A/en unknown
- 2010-11-19 UA UAA201207505A patent/UA110696C2/uk unknown
- 2010-11-19 KR KR1020127016191A patent/KR20120085330A/ko not_active Application Discontinuation
- 2010-11-19 WO PCT/US2010/057494 patent/WO2011063276A1/en active Application Filing
- 2010-11-22 US US12/951,780 patent/US8629185B2/en active Active
-
2012
- 2012-05-23 IL IL219959A patent/IL219959A/en active IP Right Grant
- 2012-05-23 CL CL2012001339A patent/CL2012001339A1/es unknown
- 2012-05-28 ZA ZA2012/03883A patent/ZA201203883B/en unknown
- 2012-06-22 CO CO12104940A patent/CO6551754A2/es unknown
-
2013
- 2013-12-20 US US14/136,323 patent/US9181176B2/en active Active
-
2015
- 2015-07-12 IL IL239892A patent/IL239892A0/en unknown
- 2015-08-25 HK HK15108218.2A patent/HK1207570A1/xx unknown
-
2016
- 2016-02-05 JP JP2016021287A patent/JP2016094471A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL219959A0 (en) | 2012-07-31 |
NZ600263A (en) | 2014-08-29 |
MX2012005968A (es) | 2012-08-15 |
IL219959A (en) | 2015-07-30 |
CO6551754A2 (es) | 2012-10-31 |
UA110696C2 (uk) | 2016-02-10 |
BR112012012387A2 (pt) | 2019-09-24 |
CL2012001339A1 (es) | 2012-08-10 |
IL239892A0 (en) | 2015-08-31 |
ZA201203883B (en) | 2013-01-31 |
CN104367580A (zh) | 2015-02-25 |
AU2010321831B2 (en) | 2016-07-07 |
CN102712584A (zh) | 2012-10-03 |
JP5921439B2 (ja) | 2016-05-24 |
JP2013511573A (ja) | 2013-04-04 |
CA2781698A1 (en) | 2011-05-26 |
IN2012DN05209A (xx) | 2015-10-23 |
AU2010321831A1 (en) | 2012-06-21 |
US20140113974A1 (en) | 2014-04-24 |
JP2016094471A (ja) | 2016-05-26 |
RU2577546C2 (ru) | 2016-03-20 |
US9181176B2 (en) | 2015-11-10 |
EP2504313A1 (en) | 2012-10-03 |
KR20120085330A (ko) | 2012-07-31 |
WO2011063276A1 (en) | 2011-05-26 |
US8629185B2 (en) | 2014-01-14 |
CN102712584B (zh) | 2014-10-29 |
RU2012125185A (ru) | 2013-12-27 |
US20110152376A1 (en) | 2011-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207570A1 (en) | 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-n- ethyl-hept-4-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof ii 7-[35--2-(3--5---1-)-]-n-- -5-() | |
IL247741B (en) | Pharmaceutical preparations containing iron oxo-hydroxide, methods for their preparation and their uses | |
HK1168584A1 (zh) | 種新的丹酚酸化合物 、其製備方法和用途 | |
ZA201004086B (en) | Rasagiline formulations, their preparation and use | |
IL202203A0 (en) | Synthetic bile acid composition, method, and preparation | |
IL214033A0 (en) | 3h-imidazo[4,5-c]pyridine-6-caboxamides as anti-inflammatory agents | |
IL200544A0 (en) | Crystalline minocycline base and processes for its preparation | |
PL1988090T3 (pl) | Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie | |
IL215684A0 (en) | Trehalulose-containing composition, its preparation and use | |
EP2307344A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, PREPARATION AND USE THEREOF | |
HK1190712A1 (zh) | 芳基氨基醇取代的 -二氫咪唑並 喹啉 | |
ZA201107232B (en) | Process for the preparation of cinacalcet and salts thereof, and intermediates for use in the process | |
EP2615100A4 (en) | FRUCTOSYL-PUERARIN, PROCESS FOR PREPARING THE SAME AND APPLICATIONS THEREOF | |
IL216105A0 (en) | Non-cating salt composition, preparation process and use thereof | |
IL216794A0 (en) | 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5]tetrazin-4-one compounds and their use | |
IL218216A0 (en) | Novel arylated camphenes, processes for their preparation and uses thereof | |
IL215286A0 (en) | 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof | |
SI2448940T1 (sl) | Derivati 6,7,8,9-tetrahidro-pirimido(1,2-a)pirimidin-4-ona, njihova priprava in njihova farmacevtska uporaba | |
PT2504331E (pt) | Composto, novas formas desse composto, composições farmacêuticas desse composto e métodos de preparação e utilização | |
IL215980A (en) | An intermediate substance of Artemnam, a preparation containing it and methods for its preparation | |
GB0918615D0 (en) | Cell populations having immunoregulatory activity, methods for the preparation and uses thereof | |
IL214211A0 (en) | Stable vaccine compositions and methods for preparing the same | |
ZA201203531B (en) | Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof | |
EP2457921A4 (en) | AUREOLIC ACID DERIVATIVES, PROCESS FOR OBTAINING THEM AND USES THEREOF | |
HK1144093A1 (en) | Sophocarpine-series derivative, and preparation method and use thereof |